Towards Healthcare
Anticoagulation Monitoring Devices Market Grows USD 3.13 Bn by 2034

Anticoagulation Monitoring Devices Market North America Leads, Asia Pacific to See Fastest Regional Growth by 2034

According to market projections, the global anticoagulation monitoring devices market, valued at USD 1.55 billion in 2024, is anticipated to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% over the next decade.Rising geriatric population across the globe, rising adoption of novel oral anticoagulants (NOACs), and growing prevalence of chronic disease are driving the growth of the market. North America dominated the global anticoagulation monitoring devices market, while Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

These devices include pointofcare systems for PT INR, ACT, and aPTT testing, enabling rapid assessment of blood clotting parameters. They are critical for managing anticoagulant therapy and tailoring treatment decisions in clinical and home settings.

Surging prevalence of cardiovascular conditions requiring anticoagulation, combined with increasing use of both traditional and direct oral anticoagulants, fuels demand. A trend toward decentralizing testing into hospitals, clinics, and home care accelerates adoption.

PTINR (anticoagulation) devices dominate usage, especially for warfarin monitoring. ACT aPTT devices serve critical care and surgery, while viscoelastic monitors are preferred in highrisk surgical and ICU settings.

High device and consumable costs, along with reimbursement uncertainty, limit broader use. However, increased smartphone EHR connectivity and remote patient monitoring offer growth potential in homebased anticoagulation care.

North America holds the largest share thanks to strong infrastructure and reimbursement frameworks. Meanwhile, Asia Pacific is the fastest-growing region, driven by rising cardiovascular burden and expanding access to diagnostics.

As of 2024, the anticoagulation monitoring devices market is valued at USD 1.55 billion. It is projected to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 to 2034.

As of 2024, the anticoagulation monitoring devices market is valued at USD 1.55 billion. It is projected to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 to 2034.

As of 2024, the anticoagulation monitoring devices market is valued at USD 1.55 billion. It is projected to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 to 2034.
Any Questions